SeekGene
寻因生物
SeekGene (寻因生物) is a single-cell sequencing technology company that was backed by ZhenFund as an angel investment . The company has been recognized in KPMG China's health technology rankings, appearing in the inaugural China HealthTech 50 list and the third Biotech Innovation 50 list .
In 2022, SeekGene partnered with Alibaba Cloud and MemVerge on a collaboration involving big-memory software . The company's work sits within the broader single-cell analysis market, which was projected to grow from $3.1 billion in 2021 to $6.3 billion by 2026 . Single-cell sequencing is described as a platform technology comparable to PCR or next-generation sequencing, applicable across life science research, clinical diagnostics, and drug development .
AI-generated — may contain errors, please verify.
Coverage
Venture Where No One Has Gone Before | Z News
July is drawing to a close, and we invite you to join us in witnessing the growth of our portfolio companies and what's new at ZhenFund.
Greener Pastures, First Flickers of Ambition | Z News
The light and shadow grow richer; a story is brewing.
Quantum Computing, 3D Sensor Chip Companies Secure New Funding; New Brands, Robotics, and Healthcare Firms Advance Globally | Rongbao · April
Summer begins, and all things grow.
